[HTML][HTML] CRISPR/Cas9: a tool to eradicate HIV-1

R Bhowmik, B Chaubey - AIDS Research and Therapy, 2022 - Springer
The development of antiretroviral therapy (ART) has been effective in suppressing HIV
replication. However, severe drug toxicities due to the therapy and its failure in targeting the …

The therapeutic application of CRISPR/Cas9 technologies for HIV

S Saayman, SA Ali, KV Morris… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: The use of antiretroviral therapy has led to a significant decrease in morbidity
and mortality in HIV-infected individuals. Nevertheless, gene-based therapies represent a …

[HTML][HTML] Elimination of infectious HIV DNA by CRISPR–Cas9

AT Das, CS Binda, B Berkhout - Current opinion in virology, 2019 - Elsevier
Highlights•HIV provirus in infected cells can be inactivated with CRISPR–
Cas9.•Combinatorial CRISPR–Cas9 attack can prevent viral escape.•Both mutation and …

Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS

Z Huang, A Tomitaka, A Raymond, M Nair - Gene therapy, 2017 - nature.com
Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) remains
a major health hazard despite significant advances in prevention and treatment of HIV …

[HTML][HTML] Application of CRISPR/Cas9-based gene editing in HIV-1/AIDS therapy

Q Xiao, D Guo, S Chen - Frontiers in cellular and infection …, 2019 - frontiersin.org
Despite the fact that great efforts have been made in the prevention and therapy of HIV-1
infection, HIV-1/AIDS remains a major threat to global human health. Highly active …

Developmental progress of CRISPR/Cas9 and its therapeutic applications for HIV‐1 infection

Q Deng, Z Chen, L Shi, H Lin - Reviews in Medical Virology, 2018 - Wiley Online Library
The CRISPR/Cas9 system has been developed as a powerful tool for targeted gene editing.
As a result of technical enhancements in recent years, this technology has become the …

CRISPR/Cas9 inhibits multiple steps of HIV-1 infection

L Yin, S Hu, S Mei, H Sun, F Xu, J Li, W Zhu… - Human Gene …, 2018 - liebertpub.com
CRISPR/Cas9 is an adaptive immune system where bacteria and archaea have evolved to
resist the invading viruses and plasmid DNA by creating site-specific double-strand breaks …

The potential use of the CRISPR‐Cas system for HIV‐1 gene therapy

GDN Sanches-da-Silva, LFS Medeiros… - International journal of …, 2019 - Wiley Online Library
The HIV‐1 virus (human immunodeficiency virus) affects 36.9 million people worldwide, with
approximately 900000 deaths in 2017. The virus carrier can develop severe …

[HTML][HTML] CRISPR-Cas12b enables a highly efficient attack on HIV proviral DNA in T cell cultures

M Fan, Y Bao, B Berkhout, E Herrera-Carrillo - Biomedicine & …, 2023 - Elsevier
Abstract Background The novel endonuclease Cas12b was engineered for targeted
genome editing in mammalian cells and is a promising tool for certain applications because …

[HTML][HTML] Application of CRISPR/Cas genomic editing tools for HIV therapy: toward precise modifications and multilevel protection

A Maslennikova, D Mazurov - Frontiers in Cellular and Infection …, 2022 - frontiersin.org
Although highly active antiretroviral therapy (HAART) can robustly control human
immunodeficiency virus (HIV) infection, the existence of latent HIV in a form of proviral DNA …